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Introduction
In the recent years many authors have reported the value
of lymphography in oncological surgery. Methods of lym-
phoscintygraphy or intraoperative staining of regional
lymph nodes were introduced to improve their identifica-
tion. The theory of the sentinel lymph node was presented
by Cabanas for penile cancer, while it was developed and
practically applied by Morton for malignant melanoma.
Basing upon their reports selective lymphography, invo-
lving intraoperative administration of the dye to the pri-
mary organ, was performed to identify the sentinel lymph
nodes for the organ. This method is used in the treat-
ment of malignant melanoma, breast cancer and penile
cancer [1-7].
Prostate cancer is a common malignancy in men
[8]. Only in case when the tumor is confined to the prosta-
te gland will the patient benefit from radical treatment [9].
Physical examination and imaging examinations allow to
assess the local stage of the disease and to exclude di-
stant metastases, but are not sensitive and specific enough
to diagnose the state of regional lymph nodes [10-14].
For such assessment histological examination is indispen-
sable [9, 10, 15].
Failure of intraoperative sentinel lymph node staining
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O b j e c t i v e s .  To evaluate the effectiveness of intraoperative Patentblau V dye injection to the prostate in the identification
of a sentinel obturatory lymph node.
M a t e r i a l  a n d  m e t h o ds . Between 1998 and 2000, the authors were attempting to stain sentinel lymph nodes in 17 patients
with prostate cancer. The patients were qualified for laparoscopic ilio-obturatory lymphadenectomy, preceding radical teleradiothe-
rapy. Patentblau V dye was given to the prostate before the onset of surgery. The effect of staining was assessed during the operation.
Re s u l t s.  No successful identification of the sentinel lymph node was observed. As a result, we abandoned further at-
tempts of sentinel lymph node staining.
C o n c l u s i o n s . Intraoperative injection of Patentblau V into the prostate gland is ineffective for the staining of sentinel lymph
nodes.
Niepowodzenie Êródoperacyjnego wybarwienia warowniczego w´z∏a ch∏onnego
podczas laparoskopowej limfadenektomii biodrowo-zas∏onowej
u chorych na raka stercza
C e l  p r a c y.  Celem pracy jest ocena skutecznoÊci wybarwienia regionalnych w´z∏ów ch∏onnych w wyniku podania barwni-
ka Patentblau V do gruczo∏u krokowego.
M a t e r i a ∏  i m e t o d y.  Od 1998 roku do 2000 roku autorzy podj´li prób´ wybarwienia w´z∏a wartowniczego u 17 chorych
na raka gruczo∏u krokowego. Pacjenci ci byli kwalifikowani do laparoskopowej limfadenektomii biodrowo – zas∏onowej przed
teleradioterapià z pól zewn´trznych. Przed przystàpieniem do zabiegu podawano do gruczo∏u krokowego barwnik Patentblau
V. Efekt wybarwienia si´ w´z∏ów ch∏onnych oceniany by∏ podczas zabiegu operacyjnego.
W y n i k i.  W ˝adnym przypadku nie stwierdzono wybarwienia si´ w´z∏a wartowniczego. Z tego powodu autorzy zrezygnowa-
li z dalszych prób wybarwiania w´z∏ów ch∏onnych.
W n i o s k i.  W przedstawianym materiale nie uzyskano wybarwienia w´z∏ów ch∏onnych po Êródoperacyjnym podaniu barw-
nika do gruczo∏u krokowego.
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The following groups of lymph nodes are conside-
red regional for the prostate gland: obturatory, external
iliac, internal iliac and lateral sacral [10, 15]. Four techni-
ques may be used to dissect ilio-obturatory lymph no-
des: open lymphadenectomy, lymphadenectomy by mini-
laparotomy and laparoscopic ilio-obturatory lymphade-
nectomy from either the transperitoneal or the
preperitoneal approach. Advantages of laparoscopy inc-
lude: minor injury, low complication rate, short hospita-
lization and rapid convalescence [10, 16]. The authors
consider laparoscopy optimal and applied it for collecting
lymph nodes.
Because of extensive lymphatic drainage of the pro-
state, the identification of the sentinel lymph node, a re-
presentative for an entiregroup of lymph nodes, could
be very useful in clinical practice. In such situations surge-
ry could be more limited and more specific.
Objectives
Evaluation of intraoperative Patentblau V dye injection to
the prostate for identification of a sentinel obturatory
lymph node.
Material
Between 29.07.1998 and 20.12.2000, laparoscopic ilio – obtura-
tory lymphadenectomy was performed in 67 patients with prosta-
te cancer, initially qualified for radical teleradiotherapy. Me-
dian age was 64 years (49-75). Clinical stage of the prostate tu-
mor ranged from T2a to T3b, stage T2b was prevailing.
The first 17 patients received a Patentblau V injection to
the prostate before the onset ofsurgery. In the following cases
authors abandoned the dye injection.
Method
The needle was inserted into prostate through the perineal re-
gion. The location of the needle was confirmed during digital
rectal examination (DRE) and 1 ml of Patentblau V was injected
into each lateral lobe. The dye was administered to 17 patients
preceding the onset of the operation by 0 to 170 minutes. The re-
sults of Patentblau injection were assessed during surgery. Each
patient received prophylactic ciprofloxacine, starting 1 hour be-
fore Patentblau V injection and continued for 2 days.
The authors assessed effectiveness of lymph nodes sta-
ining, estimating the percentage of stained lymph nodes. In 17
consecutive cases no successful staining was observed and the
authors abandoned further attempts at staining. For estima-
ting the upper limit of the method effecacy the authors assumed
that the 18th attempt at lymph node staining would be success-
ful.
Results
No successful identification of sentinel lymph node was
observed in the group of 17 consecutive patients. The es-
timated efficacy of the method, as assessed by the percen-
tage of dyed lymph nodes, is 0. The estimated upper limit
of the method efficacy is 5.5% (from 0 to 16%, 95% con-
fidence interval).
Complications were observed in 14% of patients.
One patient had obstructive ileus, requiring laparotomy,
which was assessed as major complication. Other compli-
cations were classified as minor. The complication rate
and type were identical iamong the 17 patients receiving
Patentblau V and the remaining patients. No direct com-
plications of intraoperative lymphography were observed.
Discussion
Attempts at sentinel lymph node identification by injec-
tion of dye to the tumor or its direct surrounding and
staining of the lymphatic flow were performed in several
types of cancer [8, 15-20]. In a number of centers sentinel
lymph node identification and dissection is considered
standard management in case of patients with malignant
melanoma [17, 18]. In 1981 Luciani published negative re-
sults of radioimmunonuclid injection to the prostate for
identification of lymphatic drainage [10]. The authors ha-
ve found no study, in which dye was injected intraoperati-
vly to the prostate.
In the analyzed group no successful identification
of sentinel lymph node was observed in 17 consecutive pa-
tients and the authors abandoned further attempts at
lymph node staining. Our hypothesis is that the failure is
caused by an abundancy of blood vessels and lymphatic
vessels supplying a glandular organ. Positive results of
sentinel lymph node identification published in medical li-
terature reported injectiing a dye or an isotope to the tu-
mor or its direct surrounding in cases of malignant tu-
mors of the skin or its appendages (malignant melanoma
of the skin, squamous cell carcinoma of the penis, breast
cancer) [8, 15-19].
Intraoperative lymph node staining has a documen-
ted value for melanoma patients and breast cancer pa-
tients. It allows for a more precise diagnosis and better
treatment results. Intraoperative labeling of lymph no-
des is, in fact, a procedure of growing importance [2, 3, 5,
6, 7].
There are two possibilities of lymph nodes marking:
staining with a non-toxic color agent or with a radioactive
isotope. Both methods can be combined for better re-
sults [7]. The authors chose lymph node labeling with
a color agent because the procedure seemed to be more
suitable for the identification of sentinel lymph nodes for
the prostate gland.
Conclusions
Intraoperative injection of Patentblau V into the prosta-
te is not useful for the identification of sentinel lymph
nodes in patients with prostate cancer.
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